Company: Takeda Products Ireland Ltd.

Company: Amdipharm Mercury (AMCo) Group.

Company: Rowex Ltd.

Bayer Healthcare wishes to announce that Eylea (aflibercept) injection has received European approval for the treatment of visual impairment due to diabetic macular oedema (DME).

Download pdf Lundbeck Ireland Ltd are pleased to announce that Abilify Maintena (aripiprazole once-monthly 400mg, prolonged-release suspension for  injection) has been granted European marketing authorisation for the maintenance treatment of schizophrenia in adults stabilised with oral aripiprazole.

 Download pdf Bayer HealthCare wish to announce that Eylea (aflibercept) injection has received European approval for the treatment of visual impairment due to diabetic macular oedema (DME).

Following a European-wide review of the latest safety data for Prolia, the product information for Prolia has been updated to include updated information and revised recommendations to minimise the risk of osteonecrosis of the jaw (ONJ) and hypocalcaemia during treatment.